Syros pharmaceuticals inc.

Major-Pharmaceuticals

SYRS


620 Memorial Drive
Cambridge , MA 02139

Executive/
Director

Price

  • Last Close
  • $ 1.66
    $ +0.07 4.4 %
    Aug 29, 2024
  • 52-Week High/Low
  • $7.84 - $1.5
  • YTD
  • -78.7%

  • Trading Volume
  • 5,539
  • Market Cap Full
  • $ 34.4M
  • Shares Outstanding
  • 20.7M
    Aug 4, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - 31% 33.4% 64.1% -5% -29.6% -62.9% -25.6% -31.3%
Q2 - - 1% -20.2% -13.2% 4% -26.8% -20.4% 18% -8%
Q3 - -23.6% -8.5% 14.7% 17.5% 8% -17.4% 568.7% 25.4% -
Q4 - -12.3% -38.7% -50.9% -32.4% 19.7% -27.6% -44.3% 142.7% -
J F M A M J J A S O N D
2024 -8.3% 1.7% -26.3% -13.4% - - - - - - - -
2023 42.3% -26.4% -29% 19.1% 21.1% -18.2% 26.4% -2% 1.3% -37% 10.4% 183.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%-20%-43%26%51%-69%10%117%-79%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - 0.49 -0.48 -0.49 -0.39 -0.23 -4 -0.85
Q2 - 5.42 0.52 -0.43 -0.47 -0.38 -0.36 -5.4 -1.30
Q3 - 0.65 0.53 -0.47 -0.47 -0.43 -0.41 -3.21 -1.43
Q4 - 0.47 0.58 -0.53 -0.45 -0.62 -3.8 5.12 -
A 0 6.5 2.1 -1.9 -1.9 -18.2 -13.8 -7.5 -3.58

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 32.8 43.4 61.6 62.1 20.3
Jun 32.6 42.4 45.7 61.9 62.8 20.6
Sep 33.7 42.4 45.8 61.9 63 20.7
Dec 33.7 42.4 45.8 61.9 20.2 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.8 0.7 0.8 0.1 0.4
Total Asset Turnover 0.1 0.1 0.1 - -
Leverage
Debt Ratio 0.2 0.3 0.2 - -
Debt – Equity Ratio 0.3 0.5 0.4 - -
Interest Coverage 3.3 8.3 -41 26 32
Equity multiplier 0.2 0.4 0.2 0.2 0.1